Lv41
490 积分 2023-03-16 加入
Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis
3小时前
待确认
An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis
1个月前
已完结
Strategies for targeting cytokines in inflammatory bowel disease
1个月前
已完结
TNF and TNF receptors as therapeutic targets for rheumatic diseases and beyond
1个月前
已完结
Sequential immunotherapy: towards cures for autoimmunity
1个月前
已完结
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
1个月前
已完结
Cancer therapy with antibodies
1个月前
已完结
CXCL‐10 and Interleukin‐6 are reliable serum markers for vitiligo activity: A multicenter cross‐sectional study
2个月前
已完结
Diagnosis and classification of chronic prurigo
3个月前
已完结
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
4个月前
已完结
皖公网安备34019202002308
